These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin. Rakotoniaina Z, Guerard P, Lirussi F, Goirand F, Rochette L, Dumas M, Bardou M. Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939 [Abstract] [Full Text] [Related]
6. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia. Naoumova RP, Marais AD, Mountney J, Firth JC, Rendell NB, Taylor GW, Thompson GR. Atherosclerosis; 1996 Jan 26; 119(2):203-13. PubMed ID: 8808497 [Abstract] [Full Text] [Related]
7. Oxidative stress and inflammation are differentially affected by atorvastatin, pravastatin, rosuvastatin, and simvastatin on lungs from mice exposed to cigarette smoke. Ferreira TS, Lanzetti M, Barroso MV, Rueff-Barroso CR, Benjamim CF, de Brito-Gitirana L, Porto LC, Valença SS. Inflammation; 2014 Oct 26; 37(5):1355-65. PubMed ID: 24609836 [Abstract] [Full Text] [Related]
9. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats. Hong SP, Chang KS, Choi DH, Choi JS. Arch Pharm Res; 2007 Jan 26; 30(1):90-5. PubMed ID: 17328247 [Abstract] [Full Text] [Related]
12. HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats. Satoh K, Keimatsu N, Kanda M, Kasai T, Takaguri A, Sun F, Ichihara K. Biol Pharm Bull; 2005 Nov 26; 28(11):2092-5. PubMed ID: 16272695 [Abstract] [Full Text] [Related]
13. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury. Melo AC, Valença SS, Gitirana LB, Santos JC, Ribeiro ML, Machado MN, Magalhães CB, Zin WA, Porto LC. Int Immunopharmacol; 2013 Sep 26; 17(1):57-64. PubMed ID: 23747588 [Abstract] [Full Text] [Related]
14. LIFE and ARBITER. Liebson PR. Prev Cardiol; 2003 Sep 26; 6(2):108-11. PubMed ID: 12732798 [No Abstract] [Full Text] [Related]
15. The effect of pravastatin and atorvastatin on coenzyme Q10. Bleske BE, Willis RA, Anthony M, Casselberry N, Datwani M, Uhley VE, Secontine SG, Shea MJ. Am Heart J; 2001 Aug 26; 142(2):E2. PubMed ID: 11479481 [Abstract] [Full Text] [Related]
16. Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs. Satoh K, Ichihara K. J Cardiovasc Pharmacol; 2000 Feb 26; 35(2):256-62. PubMed ID: 10672858 [Abstract] [Full Text] [Related]